Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,366
Out of 5,090 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $258.39 | +12.23% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $145.49 | -14.08% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $394.81 | -27.05% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $10.93 | +201.92% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $128.96 | +152.02% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.42 | +31.76% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $182.51 | -45.76% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $185.80 | -3.12% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $7.09 | +41.04% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $225.85 | -26.50% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $74.97 | -42.64% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $184.31 | -16.45% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $317.69 | +35.35% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $317.05 | +35.63% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $27.76 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $48.03 | -0.06% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,414.86 | -51.94% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $78.37 | -61.72% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $572.77 | -47.62% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.36 | +2,841.18% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $258.39
Upside: +12.23%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $145.49
Upside: -14.08%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $394.81
Upside: -27.05%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $10.93
Upside: +201.92%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $128.96
Upside: +152.02%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.42
Upside: +31.76%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $182.51
Upside: -45.76%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $185.80
Upside: -3.12%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $7.09
Upside: +41.04%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $225.85
Upside: -26.50%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $74.97
Upside: -42.64%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $184.31
Upside: -16.45%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $317.69
Upside: +35.35%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $317.05
Upside: +35.63%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $27.76
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $48.03
Upside: -0.06%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,414.86
Upside: -51.94%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $78.37
Upside: -61.72%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $572.77
Upside: -47.62%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.36
Upside: +2,841.18%